In terms of laboratory data, compared to the group without MetS, T2DN patients with MetS had higher levels of TC, Scr, BUN, CRP and FIB, and lower levels of HDL-C, eGFR and Hb (P<0.05) (Table 1). This evidence concerns the gene GSTM1 and metabolic syndrome.